公开(公告)号：EP4260873A1

公开(公告)日：2023-10-18

申请号：EP21906560.4

申请日：2021-12-13

申请人： Saitama Medical University

发明人： INOUE, Satoshi ,  IKEDA, Kazuhiro ,  INOUE, Kuniko ,  KAMADA, Shuhei ,  KAWAKAMI, Satoru

IPC分类号： A61K45/06 ,  A61K31/40 ,  A61K31/403 ,  A61K31/404 ,  A61K31/4162 ,  A61K31/44 ,  A61K31/4439 ,  A61K31/47 ,  A61K31/496 ,  A61K31/4985 ,  A61K31/506 ,  A61K31/513 ,  A61K31/519 ,  A61K31/522 ,  A61K31/713 ,  A61K48/00 ,  A61P35/00 ,  A61P43/00 ,  C12N9/99 ,  C12N15/11 ,  C12N15/113

摘要： The present invention relates a combination drug for treating a renal cancer and a potentiator for therapeutic effects of a tyrosine kinase inhibitor. The combination drug includes a combination of a tyrosine kinase inhibitor, and a dipeptidyl peptidase-4 inhibitor. The potentiator includes a dipeptidyl peptidase-4 inhibitor. The potentiator enhances therapeutic effects of a tyrosine kinase inhibitor on a renal cancer.